Polaris Quantum Biotech

Polaris Quantum Biotech

Early Stage

Drug blueprints to treat and cure all diseases for all people

Drug blueprints to treat and cure all diseases for all people


Funding data not publicly available


Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Convertible Note



SEC Filing Type

RegD 506(c)

Valuation Cap




Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model



Capital Intensity



Durham, North Carolina

Business Type


Polaris Quantum Biotech, with a valuation of $40 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company uses the latest innovations in cloud and quantum computing, artificial intelligence, and machine learning to develop new drugs in a fraction of the time and cost of conventional methods. The platform and technology of Polaris Quantum Biotech scan billions of molecules from a large chemical space to find the molecules most suitable for drug development. Dr. Shahar Keinan and Bill Shipman founded Polaris Quantum Biotech in 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,120,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Polaris Quantum Biotech 10/09/2022 OurCrowd $40,000,000 - Convertible Note Funded RegD 506(c)
Polaris Quantum Biotech 07/22/2021 OurCrowd $11,500,000 - Equity - Common Funded RegD 506(c)
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Polaris Quantum Biotech on OurCrowd 2022
Platform: OurCrowd
Security Type: Convertible Note
Valuation: $40,000,000

Follow company

Follow Polaris Quantum Biotech on OurCrowd 2022

Buy Polaris Quantum Biotech's Deal Report

Warning: according to the close date for this deal, Polaris Quantum Biotech may no longer be accepting investments.

Polaris Quantum Biotech Deal Report

Get KingsCrowd’s comprehensive report on Polaris Quantum Biotech including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Polaris Quantum Biotech is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Polaris Quantum Biotech deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge